Zepbound — Medica
Obstructive sleep apnea, moderate to severe, in a patient with obesity
Initial criteria
- age ≥ 18 years
- current BMI ≥ 30 kg/m2
- sleep study showing diagnosis of moderate to severe OSA with apnea-hypopnea index ≥ 15 events/hour
- does not have central sleep apnea with ≥ 50% central apneas/hypopneas AND does not have Cheyne Stokes respiration
- used concomitantly with behavioral modification and reduced-calorie diet
Reauthorization criteria
- age ≥ 18 years
- baseline BMI ≥ 30 kg/m2
- has completed ≥ 1 year of Zepbound therapy
- has lost ≥ 10% of baseline body weight
- has stability in OSA signs or symptoms (e.g., snoring, daytime sleepiness, fatigue)
- used concomitantly with behavioral modification and reduced-calorie diet
Approval duration
1 year